ID19257A - Protein-protein anti-obesitas - Google Patents

Protein-protein anti-obesitas

Info

Publication number
ID19257A
ID19257A IDP973915A ID973915A ID19257A ID 19257 A ID19257 A ID 19257A ID P973915 A IDP973915 A ID P973915A ID 973915 A ID973915 A ID 973915A ID 19257 A ID19257 A ID 19257A
Authority
ID
Indonesia
Prior art keywords
obesity proteins
obesity
proteins
Prior art date
Application number
IDP973915A
Other languages
English (en)
Inventor
John Michael Beals
Ronald Eugene Chance
James Arthur Hoffmann
Rohm Lee Millican Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID19257A publication Critical patent/ID19257A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Plant Pathology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDP973915A 1996-12-20 1997-12-18 Protein-protein anti-obesitas ID19257A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3356196P 1996-12-20 1996-12-20

Publications (1)

Publication Number Publication Date
ID19257A true ID19257A (id) 1998-06-28

Family

ID=21871119

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP973915A ID19257A (id) 1996-12-20 1997-12-18 Protein-protein anti-obesitas

Country Status (23)

Country Link
EP (1) EP0849276A1 (id)
JP (1) JPH10179158A (id)
KR (1) KR19980064258A (id)
CN (1) CN1194986A (id)
AR (1) AR013886A1 (id)
AU (2) AU4843297A (id)
BR (1) BR9706358A (id)
CA (1) CA2217698A1 (id)
CO (1) CO4700343A1 (id)
CZ (1) CZ407097A3 (id)
HU (1) HUP9702500A3 (id)
ID (1) ID19257A (id)
IL (1) IL122569A0 (id)
NO (1) NO975938L (id)
NZ (1) NZ329413A (id)
PE (1) PE47599A1 (id)
PL (1) PL323956A1 (id)
SG (1) SG65040A1 (id)
SV (1) SV1997000107A (id)
TR (1) TR199701666A2 (id)
WO (1) WO1998028335A1 (id)
YU (1) YU48997A (id)
ZA (1) ZA9710877B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK141899A3 (en) 1997-04-15 2000-09-12 Csir Corporate Building Pharmaceutical compositions having appetite suppressant activity
AU2893199A (en) * 1998-03-03 1999-09-20 Board Of Regents, The University Of Texas System Fatty acid-induced beta-cell apoptosis
GB9924484D0 (en) * 1999-10-15 1999-12-15 Isis Innovation Altered polypeptide aggregation
GB2396815B (en) 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
US7022674B2 (en) 1999-12-16 2006-04-04 Eli Lilly And Company Polypeptide compositions with improved stability
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
EP2030628B1 (en) 2006-06-01 2012-08-15 Yun Cheng A peptide for preventing or treating liver damage and its derivant and the use
US12466883B1 (en) * 2024-05-13 2025-11-11 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5827734A (en) * 1995-01-20 1998-10-27 University Of Washington Materials and methods for determining ob protein in a biological sample
EP0725079A1 (en) * 1995-01-31 1996-08-07 Eli Lilly And Company Anti-obesity proteins
AU4862396A (en) * 1995-02-06 1996-08-27 Eli Lilly And Company Human obesity gene
AU5539596A (en) * 1995-04-06 1996-10-23 Amylin Pharmaceuticals, Inc. Anti-obesity agents
GB9509164D0 (en) * 1995-05-05 1995-06-28 Smithkline Beecham Plc Novel compounds
AU6284896A (en) * 1995-06-22 1997-01-22 Eli Lilly And Company Obesity protein intermediates and their preparation and use

Also Published As

Publication number Publication date
EP0849276A1 (en) 1998-06-24
AU5384698A (en) 1998-07-17
HUP9702500A3 (en) 1999-07-28
ZA9710877B (en) 1999-06-03
CO4700343A1 (es) 1998-12-29
SV1997000107A (es) 1999-01-18
AR013886A1 (es) 2001-01-31
WO1998028335A1 (en) 1998-07-02
JPH10179158A (ja) 1998-07-07
NO975938D0 (no) 1997-12-17
NO975938L (no) 1998-06-22
SG65040A1 (en) 1999-05-25
TR199701666A3 (tr) 1999-10-21
PL323956A1 (en) 1998-06-22
BR9706358A (pt) 1999-05-04
HU9702500D0 (en) 1998-03-02
NZ329413A (en) 1999-10-28
IL122569A0 (en) 1998-06-15
AU4843297A (en) 1998-06-25
CZ407097A3 (cs) 1998-07-15
TR199701666A2 (xx) 1999-10-21
PE47599A1 (es) 1999-05-14
CA2217698A1 (en) 1998-06-20
CN1194986A (zh) 1998-10-07
HUP9702500A2 (hu) 1998-07-28
KR19980064258A (ko) 1998-10-07
YU48997A (sh) 1999-09-27

Similar Documents

Publication Publication Date Title
FI973162A0 (fi) Liikalihavuutta vastustavia proteiineja
FI965225A7 (fi) Uusia peptidejä
FI961350L (fi) Hapteenimerkityt peptidit
EP0853483A4 (en) NEW PEPTIDES
FI972312L (fi) Uusia siiliperäisiä polypeptidejä
DE69735926D1 (de) Interleukin-18 Rezeptorproteine
FI954147L (fi) Polypeptidejä
BR9709529A (pt) Fragmentos de leptina (proteína ob)
NO985680L (no) Peptidderivater
IS4459A (is) Ný peptíð er hafa ónæmisbreytandi áhrif
NO983849L (no) Peptidderivater
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
FI940109A0 (fi) Peptidejä
FI970168A0 (fi) Peptidejä
FI964363L (fi) Peptidejä
NO975938D0 (no) Anti-fedme proteiner
FI972215A7 (fi) Uusia polypeptidejä
DK0950063T3 (da) Flergrenede peptidkonstruktioner
EP1007648A4 (en) ANTI-OBESITY PROTEINS
DE69615850D1 (de) G-protein-gekoppelter rezeptor hnfd578
NO973515D0 (no) Anti-fedme proteiner
SE9602361D0 (sv) Plant proteins/peptides
SE9601085D0 (sv) Novel polypeptides
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider